Therapeutic area intelligence for Brain Metastases with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 1

Companies

Euraxi Pharma →

Assets

No related entities indexed yet.

Recent signals(2)

ClinicalJuly 30, 2026

Study on Neoadjuvant vs Adjuvant Stereotactic Radiotherapy for Brain Metastases

This study aims to compare local control rates of neoadjuvant stereotactic radiotherapy versus adjuvant treatment in brain metastases.

ClinicalJune 20, 2026

Study on Neuropsychological Changes in Brain Metastases Patients Undergoing Radiation Therapy

The study aims to evaluate cognitive and daily functioning changes in patients receiving radiation therapy for brain metastases.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.